VP Research & Development
Dr. Hochman holds a PhD in cancer Immunology from the Sackler School of Medicine, Tel Aviv University. Dr. Hochman brings more than 20 years of experience in versatile R&D leadership and management positions in Innovative biotechnology and startup companies. Before joining Cannabics, Dr. Hochman was a co-founder and VP of R&D at SURI Technologies, a company focusing on developing personalized cancer immunotherapy. Previously he was the founder of Biology Research Services, a company that provided Tailor-made solutions for startups research, and managed the Bioassay and HTS units at QBI and Rosetta Genomics.
